290 related articles for article (PubMed ID: 7586221)
1. T-cell lymphokines, interleukin-4 and gamma interferon, modulate the induction of vascular smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor.
Wang W; Chen HJ; Giedd KN; Schwartz A; Cannon PJ; Rabbani LE
Circ Res; 1995 Dec; 77(6):1095-106. PubMed ID: 7586221
[TBL] [Abstract][Full Text] [Related]
2. T cell lymphokines modulate bFGF-induced smooth muscle cell fibrinolysis and migration.
Wang W; Chen HJ; Schwartz A; Cannon PJ; Rabbani LE
Am J Physiol; 1997 Feb; 272(2 Pt 1):C392-8. PubMed ID: 9124280
[TBL] [Abstract][Full Text] [Related]
3. Effects of S-dC28 on vascular smooth muscle cell adhesion and plasminogen activator production.
Wang W; Chen HJ; Warshofsky M; Schwartz A; Stein CA; Rabbani LE
Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):101-7. PubMed ID: 9149845
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-4 Modulation of Platelet-Derived Growth Factor-Induced Smooth Muscle Cell Urokinase Plasminogen Activator.
Wang W; Chen HJ; Yazdani S; Simon A; Schwartz A; Rabbani LE
J Thromb Thrombolysis; 1998 May; 5(2):119-123. PubMed ID: 10767105
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture.
Louwrens HD; Kwaan HC; Pearce WH; Yao JS; Verrusio E
Eur J Vasc Endovasc Surg; 1995 Oct; 10(3):289-93. PubMed ID: 7552526
[TBL] [Abstract][Full Text] [Related]
6. Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells.
Herbert JM; Lamarche I; Carmeliet P
J Biol Chem; 1997 Sep; 272(38):23585-91. PubMed ID: 9295297
[TBL] [Abstract][Full Text] [Related]
7. Pathogenetic implications of hyaluronan-induced modification of vascular smooth muscle cell fibrinolysis in diabetes.
Marutsuka K; Woodcock-Mitchell J; Sakamoto T; Sobel BE; Fujii S
Coron Artery Dis; 1998; 9(4):177-84. PubMed ID: 9649923
[TBL] [Abstract][Full Text] [Related]
8. Regulation of proteolytic enzymes and inhibitors in two smooth muscle cell phenotypes.
Lau HK
Cardiovasc Res; 1999 Sep; 43(4):1049-59. PubMed ID: 10615432
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion.
Okada SS; Grobmyer SR; Barnathan ES
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1269-76. PubMed ID: 8857924
[TBL] [Abstract][Full Text] [Related]
10. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder BR
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):723-30. PubMed ID: 9108786
[TBL] [Abstract][Full Text] [Related]
11. Regulation of baboon arterial smooth muscle cell plasminogen activators by heparin and growth factors.
Kenagy RD; Clowes AW
Thromb Res; 1995 Jan; 77(1):55-61. PubMed ID: 7701477
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
[TBL] [Abstract][Full Text] [Related]
13. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.
Wojta J; Gallicchio M; Zoellner H; Hufnagl P; Last K; Filonzi EL; Binder BR; Hamilton JA; McGrath K
Thromb Haemost; 1993 Sep; 70(3):469-74. PubMed ID: 8259551
[TBL] [Abstract][Full Text] [Related]
14. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation.
Xiaoli M; Wenying H; Mingpeng S
Int J Cardiol; 1998 Oct; 66 Suppl 1():S57-64; discussion S65. PubMed ID: 9951803
[TBL] [Abstract][Full Text] [Related]
15. The effect of endothelial cell overexpression of plasminogen activator inhibitor-1 on smooth muscle cell migration.
Proia RR; Nelson PR; Mulligan-Kehoe MJ; Wagner RJ; Kehas AJ; Powell RJ
J Vasc Surg; 2002 Jul; 36(1):164-71. PubMed ID: 12096275
[TBL] [Abstract][Full Text] [Related]
16. Heparin and dibutyryl cAMP modulate gene expression in stimulated human saphenous vein smooth muscle cells.
Yamaguchi M; Diamond S; Watanabe H; Gallati H; Baur W; Sharefkin JB
In Vitro Cell Dev Biol Anim; 1993 Nov; 29A(11):867-72. PubMed ID: 8167903
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells.
Reilly CF; McFall RC
J Biol Chem; 1991 May; 266(15):9419-27. PubMed ID: 2033043
[TBL] [Abstract][Full Text] [Related]
18. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS
Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585
[TBL] [Abstract][Full Text] [Related]
19. Expression of the plasminogen activator system in the human vascular wall.
Salame MY; Samani NJ; Masood I; deBono DP
Atherosclerosis; 2000 Sep; 152(1):19-28. PubMed ID: 10996335
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells.
Ekhterae D; Stanley JC
J Vasc Surg; 1995 Jun; 21(6):953-62. PubMed ID: 7776475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
